These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 1444359)
1. Quantitation of E. coli protein impurities in recombinant human interferon-gamma. Chen AB; Championsmith AA; Blanchard J; Gorrell J; Niepelt BA; Federici MM; Formento J; Sinicropi DV Appl Biochem Biotechnol; 1992 Aug; 36(2):137-52. PubMed ID: 1444359 [TBL] [Abstract][Full Text] [Related]
2. Immunoassay for the detection of E. coli proteins in recombinant DNA derived human growth hormone. Anicetti VR; Fehskens EF; Reed BR; Chen AB; Moore P; Geier MD; Jones AJ J Immunol Methods; 1986 Jul; 91(2):213-24. PubMed ID: 3525680 [TBL] [Abstract][Full Text] [Related]
3. Differential purification by immunoaffinity chromatography of two carboxy-terminal portion-deleted derivatives of recombinant human interferon-gamma from Escherichia coli. Honda S; Asano T; Kajio T; Nakagawa S; Ikeyama S; Ichimori Y; Sugino H; Nara K; Kakinuma A; Kung HF J Interferon Res; 1987 Apr; 7(2):145-54. PubMed ID: 3112244 [TBL] [Abstract][Full Text] [Related]
4. Analysis of antibody response in patients receiving recombinant Escherichia coli-derived human interferon-gamma. Liang CM; Herren S; Fountoulakis M; Otto B; Hirschi M; Gutzwiller E; Gerlis L Clin Immunol Immunopathol; 1985 Jul; 36(1):95-100. PubMed ID: 2988841 [TBL] [Abstract][Full Text] [Related]
5. Monoclonal antibodies to a recombinant human leukocyte interferon (rIFN-alpha B). Osheroff PL; Tahara SM; Chiang TR Clin Immunol Immunopathol; 1984 Feb; 30(2):188-96. PubMed ID: 6692601 [TBL] [Abstract][Full Text] [Related]
6. Escherichia coli-derived human interferon-gamma with Cys-Tyr-Cys at the N-terminus is partially N alpha-acylated. Honda S; Asano T; Kajio T; Nishimura O Arch Biochem Biophys; 1989 Mar; 269(2):612-22. PubMed ID: 2493219 [TBL] [Abstract][Full Text] [Related]
7. [Obtaining antibodies and development of an immunoassay for the detection of Escherichia coli proteins in preparations of human recombinant gamma interferon]. Díaz N; Santana H; Cruz M; Brito R; Maso Y; Pérez E; Furrazola G Rev Argent Microbiol; 1998; 30(2):64-72. PubMed ID: 9744032 [TBL] [Abstract][Full Text] [Related]
8. Increased coating efficiency of antigens and preservation of original antigenic structure after coating in ELISA. Jitsukawa T; Nakajima S; Sugawara I; Watanabe H J Immunol Methods; 1989 Jan; 116(2):251-7. PubMed ID: 2463315 [TBL] [Abstract][Full Text] [Related]
9. Refolding and single-step purification of porcine interferon-gamma from Escherichia coli inclusion bodies. Conditions for reconstitution of dimeric IFN-gamma. Vandenbroeck K; Martens E; D'Andrea S; Billiau A Eur J Biochem; 1993 Jul; 215(2):481-6. PubMed ID: 8344315 [TBL] [Abstract][Full Text] [Related]
10. Purification and structural characterization of recombinant rat gamma-interferon from Escherichia coli. Lai CY; Dharm E; Fujii Y Anal Biochem; 1989 Feb; 176(2):326-9. PubMed ID: 2500869 [TBL] [Abstract][Full Text] [Related]
11. Binding of unglycosylated and glycosylated human recombinant interferon-gamma to cellular receptors. Littman SJ; Devos R; Baglioni C J Interferon Res; 1985; 5(3):471-6. PubMed ID: 2932505 [TBL] [Abstract][Full Text] [Related]
13. Production and characterization of recombinant canine interferon-gamma from Escherichia coli. Zucker K; Lu P; Asthana D; Carreno M; Yang WC; Esquenazi V; Fuller L; Miller J J Interferon Res; 1993 Apr; 13(2):91-7. PubMed ID: 8509660 [TBL] [Abstract][Full Text] [Related]
14. Clinical and biological effects of intraperitoneal injections of recombinant interferon-gamma and recombinant interleukin 2 with or without tumor-infiltrating lymphocytes in patients with ovarian or peritoneal carcinoma. Freedman RS; Kudelka AP; Kavanagh JJ; Verschraegen C; Edwards CL; Nash M; Levy L; Atkinson EN; Zhang HZ; Melichar B; Patenia R; Templin S; Scott W; Platsoucas CD Clin Cancer Res; 2000 Jun; 6(6):2268-78. PubMed ID: 10873077 [TBL] [Abstract][Full Text] [Related]
15. Effects of interferons on cultured human melanocytes in vitro: interferon-beta but not-alpha or -gamma inhibit proliferation and all interferons significantly modulate the cell phenotype. Krasagakis K; Garbe C; Krüger S; Orfanos CE J Invest Dermatol; 1991 Aug; 97(2):364-72. PubMed ID: 1712824 [TBL] [Abstract][Full Text] [Related]
16. Antibody delivery and effector cell activation in a phase II trial of recombinant gamma-interferon and the murine monoclonal antibody CO17-1A in advanced colorectal carcinoma. Weiner LM; Moldofsky PJ; Gatenby RA; O'Dwyer J; O'Brien J; Litwin S; Comis RL Cancer Res; 1988 May; 48(9):2568-73. PubMed ID: 3128400 [TBL] [Abstract][Full Text] [Related]
17. Binding and cross-linking of recombinant mouse interferon-gamma to receptors in mouse leukemic L1210 cells; interferon-gamma internalization and receptor down-regulation. Wietzerbin J; Gaudelet C; Aguet M; Falcoff E J Immunol; 1986 Apr; 136(7):2451-5. PubMed ID: 2936825 [TBL] [Abstract][Full Text] [Related]
18. Production, purification, and chemical stability of recombinant human interferon-γ in low oxygen tension condition: a formulation approach. Malek-Sabet N; Masoumian MR; Zeinali M; Khalilzadeh R; Mousaabadi JM Prep Biochem Biotechnol; 2013; 43(6):586-600. PubMed ID: 23742090 [TBL] [Abstract][Full Text] [Related]
19. Characterization of human interferon-gamma and human interleukin-2 from recombinant mammalian cell lines and peripheral blood lymphocytes. Riske FJ; Cullen BR; Chizzonite R Lymphokine Cytokine Res; 1991 Jun; 10(3):213-8. PubMed ID: 1909189 [TBL] [Abstract][Full Text] [Related]
20. The production and biological assessment of cervine interferon gamma. Slobbe L; Lockhart E; Kelly J; Buchan G Cytokine; 2000 Aug; 12(8):1211-7. PubMed ID: 10930298 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]